drugset / Trial / NCT06780254
A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of Single- and Multiple-Ascending Doses of MH-001 in Healthy Volunteers
Phase 1
Completed
58 enrolled
Vespina Lifesciences Inc.
PrimeVigilance Ltd., UK · collabSyneos Health · collab
RandomizedParallel-groupQuadruple-blindBasic science
Summary
First-in-Human study to demonstrate the safety and tolerability of single- and multiple-ascending doses of MH-001 in Healthy Volunteers (HVs)
Timeline
- Start
- 2024-09-09
- Primary completion
- 2025-05-29
- Completion
- 2025-06-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MH-001 | Unknown | — | — |
Indications
No indication recorded.